FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to the chemical-pharmaceutical industry and deals with application of fullerene derivatives of the general formula 1
,
where in the general formula 1 fragment C2n stands for: fullerene carbon cage C60 (n=30), C70 (n=35); where in the general formula 1 "x" can take values from 4 to 12, and "y" from 0 to 16, where in the general formula 1 fragment A stands for a monovalent atom of fluorine or hydrogen; -oxygen atom (-O-), bound to the fullerene cage in a composition of an oxirane fragment; where in the general formula 1 NR1R2 is described by the following definitions: - amine residue, where R1 and R2 are hydrogen atoms or substituted with protonated (NH3 +) or unprotonated (NH2) aminogroups or branched alkyl radicals (CmH2m+1; m=1-20); - residue of piperazine of the general formula Ic-1 , where R, R'1, R'2 R'3 and R'4 are hydrogen atoms or linear or branched alkyl (CmH2m+1 m=1-20) radicals, as antimicrobial preparations, as well as an antimicrobial composition, including fullerene derivatives.
EFFECT: invention can be used in biomedical research and in production of novel medications, intended for treatment and prevention of infectious diseases, as well as for creation of disinfection agents, intended for decontamination and sterilisation of media and surfaces contaminated with microorganisms.
2 cl, 4 ex, 2 tbl, 4 dwg
Title | Year | Author | Number |
---|---|---|---|
USING PENTAAMINOFULLERENES AS ANTIMICROBIAL AGENTS AND ANTIMICROBIAL COMPOSITION BASED THEREON | 2011 |
|
RU2501785C2 |
PHOSPHORUS-CONTAINING DERIVATIVES OF FULLERENE C, AND THEIR PRODUCTION METHOD | 2011 |
|
RU2509083C2 |
ARYLATED POLYCARBOXYL FULLERENE DERIVATIVES, METHODS FOR PRODUCING THEM, COVALENT CONJUGATES, METHOD FOR PRODUCING THEM | 2012 |
|
RU2567299C2 |
USE OF WATER-SOLUBLE FULLERENE DERIVATIVES AS MEDICINAL PREPARATIONS OF NEUROPROTECTIVE AND ANTINEOPLASTIC ACTION | 2017 |
|
RU2704483C2 |
SULPHUR-CONTAINING FULLERENE DERIVATIVES AND METHOD FOR PRODUCTION THEREOF | 2011 |
|
RU2477273C2 |
METHOD OF PRODUCING CYCLOPROPANE FULLERENE DERIVATIVES, USE OF ORGANIC FULLERENE DERIVATIVES AS MATERIALS FOR ELECTRONIC SEMICONDUCTOR DEVICES, ORGANIC FIELD-EFFECT TRANSISTOR, ORGANIC PHOTOVOLTAIC CELL, ORGANIC FIELD-EFFECT TRANSISTOR AND ORGANIC PHOTOVOLTAIC CELL | 2011 |
|
RU2519782C2 |
METHOD OF PRODUCING FULLERENE C | 2010 |
|
RU2456233C2 |
USE OF PENTAAMINO ACID DERIVATIVES OF FULLERENES AS ANTIOXIDANTS AND ANTIDIABETIC AGENTS | 2016 |
|
RU2669341C2 |
NANOAGGREGATES OF WATER-SOLUBLE FULLERENE DERIVATIVES, METHOD FOR PREPARING THEM, COMPOSITIONS BASED ON NANOAGGREGATES OF WATER-SOLUBLE FULLERENE DERIVATIVES, USING NANOAGGREGATES OF WATER-SOLUBLE FULLERENE DERIVATIVES AND BASED COMPOSITIONS AS BIOLOGICALLY ACTIVE COMPOUNDS FOR REDUCING TOXICITY AND ENHANCING THERAPEUTIC ACTION OF DRUG PREPARATIONS, AND ALSO AS PREPARATIONS FOR TREATING ONCOLOGIC DISEASES | 2012 |
|
RU2550030C2 |
METHOD OF OBTAINING PRODUCTS WITH ANTIBACTERIAL ACTIVITY FROM THE MYCELIUM OF BASIDIOMYCETES | 2022 |
|
RU2800356C1 |
Authors
Dates
2014-07-10—Published
2011-08-30—Filed